NCT00775762

Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 213 (estimated)
• Sponsor: Catholic University of the Sacred Heart · Academic / Other
• Sex: All
• Age: 40 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a monocentric, randomized, opened study to assess the anti-inflammatory and anti-platelet effect of Clopidogrel and aspirin versus aspirin or clopidogrel alone in patients with symptomatic polyvascular disease and with multiple recurrent cardiovascular events.

Conditions

• Polyvascular Disease
• Cardiovascular Disease

Interventions

Type	Name	Description
DRUG	aspirin	Aspirin (75-100 mg)die for three months
DRUG	clopidogrel	Clopidogrel (75mg) die for three months
DRUG	clopidogrel plus aspirin	clopidogrel 75 mg die plus aspirin 75-100 mg for three months

Timeline

• Start date: 2008-11-01
• Primary completion: 2009-01-01
• Completion: 2010-12-01
• First posted: 2008-10-20
• Last updated: 2008-10-20

Locations

1 site across 1 country: Italy